Learning Objectives:
• Learners will gain a clear understanding of how GLP-1 receptor agonists function in regulating blood glucose levels and promoting weight loss, focusing on their pharmacological actions
• Learners will analyze the latest GLP-1 medications that have been approved in recent years, including their unique features, indications, and clinical advantages compared to older treatment options
• Learners will assess and evaluate the findings from recent clinical trials related to the efficacy, safety, and potential cardiovascular benefits of newer GLP-1 medications
• Learners will weigh the considerations for selecting appropriate candidates for GLP-1 therapy, including comorbid conditions and individual patient needs, to improve personalized treatment approaches
• Learners will review the common side effects associated with GLP-1 medications and discuss strategies for managing these side effects effectively to enhance patient adherence
• Learners will learn to articulate and provide practical guidance to their patients on how to incorporate GLP-1 receptor agonists into comprehensive diabetes management plans, including coordination with other antidiabetic therapies and lifestyle modifications
Accreditation Statements:
VOCCME is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS), the Georgia Osteopathic Medical Association (GOMA), the Montana Osteopathic Medical Association (MOMA), the North Carolina Osteopathic Medical Association (NCOMA), the Ohio Osteopathic Association (OOA), the Osteopathic Physicians and Surgeons of Oregon (OPSO), and the Tennessee Osteopathic Medical Association (TOMA). Each of these osteopathic associations is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
VOCCME has been designated for a maximum of 1 AOA Category 1-A credits by the VOC sponsors, who have authorized MAOPS to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
MAOPS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MAOPS designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure:
The VOCCME Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients relative to the content of these presentations.
AOA Grievance Policy:
All grievances should be in writing and specify the nature of the grievance. Initially, all grievances should be directed to the MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial written response within 30 days of receipt. If a participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.